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1. Introduction 
The cardiac action potential is arised by the highly orchestrated activity of dozens of ion 
channel proteins. These transmembrane proteins govern the influx of ion across the 
sarcolemma of cardiomyocytes generating the ionic currents responsible for excitation. In 
order to myocardium contract and ensure rhythmic pump function, the long-lasting action 
potential of the working myocardium maintains a refractory state. Because some channels 
must recover from inactivation after-repolarization before they have ability of re-opening, 
and during this time, the myocardial cells remain refractory for re-excitation. 
Typical normal action potentials consist of five distinct phases (Figure 1). Na+ influx triggers 
a rapid depolarization (phase 0) followed by an early fast repolarization phase (phase 1) and  
 
 
Fig. 1. (cited from The Sicilian gambit, 2008). Currents of sodium, calcium and potassium 
channels underlie the atrial and ventricular action potential. 
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a plateau phase (phase 2), in which repolarization is slowed due to the activation of inward 
Ca2+ current. During the final rapid repolarization phase (phase 3), membrane potential 
returns to the resting level (phase 4). Therefore, normal action potentials attributed to the 
normal function of ion channel participated to formation of action potentials.  
1.1 Ion channels in human heart disease 
Regular excitation is formed by normal AP which generated in the sino-atrial node and 
spreads throughout the heart in an orderly manner. Oppositely, disorganization of electrical 
activity is the basis of cardiac arrhythmias. Arrhythmias are caused by the perturbation of 
physiological impulse formation, impaired impulse conduction, or disturbed electrical 
recovery. Abnormal excitability of myocardial cells may give rise to kinds of cardiac 
diseases.  
The most ordinary cardiac arrhythmia diseases was inherited long QT syndrome (LQTS) 
which was recognized 40 years ago as 2 distinct clinical phenotypes, such as the Romano-
Ward and the Jervell and Lange-Nielsen syndromes. Interestingly, while LQTS was initially 
thought to be a pure cardiac channelopathy, it is now clear that non-ion-channel encoding 
genes may also cause the desease. Nevertheless, LQTs attributed to dysfunctions of ionic 
currents, either directly (ion channel) or indirectly (chaperones and/or other modulators). 
To date, 12 forms of inherited LQTS described because LQTS arise from polygenic causes 
and 9 of them directly combine with ion channels (Table 1). LQT1, 2, 5, and 6 are referred to 
prolong the plateau of cardiac APs (phase 2) by reducing K+ channel currents activated 
during depolarization. LQT1 and 5 are caused by mutations in KCNQ1 (KvLQT1) and 
KCNE1 (MinK), which encode the  and ancillary  subunits, respectively and together 
form the slowly activating delayed rectifier K+ current (IKs). LQT2 and 6 are caused by 
mutations in KCNH2 (human-ether a-go-go-related gene; HERG) and KCNE2 (MiRP1), 
which encode the  and putative  subunits, respectively and together form the rapidly 
activating delayed rectifier K+ current (IKr). LQT7 is characterized by mutations in KCNJ2 
(Kir2.1), which reduces the inward rectifier K+ channel current (IK1) to slow the return of the 
membrane to the resting potential. These cause failure of normal inactivation to decrease of 
K+ current (loss of function) and abbreviate action potentials. Besides potassium channel, 
LQT3, 10 attributed to mutations in hNaV1.5 (SCN5a), and SCNb4, which encode  and 
ancillary  subunits of Na+ channel. LQT8 are determined by mutation in CACNA1c, which 
encode alpha subunit of calcium channel. LOT3,10 and LQT8 arise from the increase of Na+ 
currents and Ca2+ currents, respectively, for prolong action potential. Therefore, “loss of 
function” or “gain of function” mutations in the affected ion channels are often formed 
different phenotypes of cardiac arrhythmia desease.  
Except the mentioned above, LQT4,9,11,12 are determined by mutation in ANK2, Cav3, 
AKAP9 and SNTA1, which encode ankyrin B, caveolin, A-kinase-anchoring protein and 
alphal1-syntrophin, respectively. All proteins increase or decrease the ironic currents (loss of 
function or gain of function). Although the remarkable genetic heterogeneity in LQT, three 
genes, such as KCNQ1 (LQT1), KCNH2 (LQT2) and SCN5A (LQT3), are dominant and 
cover more than 90 percentage of LQTS patients with identified mutations. 
With exception of LQTS, some of these involve gain of function mutations in K+ channels 
(short QT syndrome) and loss of function mutations in and Ca channel and Na+ channels 
(Brugada syndrome, cardiac conduction disease, etc). Additional congenital arrhythmia 
syndromes continue to be described, and these are summarized in Table 1. 
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current  disease  gene name  
chromosomal 
locus 
Protein 
functional 
effect 
inheritance 
INa LQT3 SCN5A 3p21 
sodium channel 
alpha subunit 
(Nav1.5) 
gain of 
function 
AD 
 BrS1 SCN5A 3p21 
sodium channel 
alpha subunit 
(Nav1.5) 
loss of 
function 
AD 
 AF3 SCN5A 3p21 
sodium channel 
alpha subunit 
(Nav1.5) 
loss of 
function 
AD 
 PCCD SCN5A 3p21 
sodium channel 
alpha subunit 
(Nav1.5) 
loss of 
function 
AD 
 SSS SCN5A 3p21 
sodium channel 
alpha subunit 
(Nav1.5) 
loss of 
function 
AD 
 LQT10 SCNb4 11q23.3 
sodium channel 
beta subunit  
increas 
sodium 
channel 
AD 
ICa,L TS/LQT8 CACNA1C 12p13.3 
calcium channel 
alpha subunit 
gain of 
function 
AD/mosaicism 
 BrS3 CACNA1C 12p13.3 
calcium channel 
alpha subunit 
loss of 
function 
AD 
 BrS4 CACNB2b 10p12 
calcium channel 
alpha subunit 
 AD 
IKS LQT1 KCNQ1 11p15.5 
IKs potassium 
channel alpha 
subunit (KvLQT1) 
loss of 
function 
AD 
 JLN1 KCNQ1 11p15.5 
IKs potassium 
channel alpha 
subunit (KvLQT1) 
gain of 
function 
AR 
 AQT2 KCNQ1 11p15.5 
IKs potassium 
channel alpha 
subunit (KvLQT1) 
gain of 
function 
AD 
 AF1 KCNQ1 11p15.5 
IKs potassium 
channel alpha 
subunit (KvLQT1) 
gain of 
function 
AD 
 LQT5 KCNE1 21q21.1-q22.2 
IKs potassium 
channel beta 
subunit (Mink) 
loss of 
function 
AD 
 JLN2 KCNE1 21q21.1-q22.2 
IKs potassium 
channel beta 
subunit (Mink) 
gain of 
function 
AR 
 AF5 KCNE1 21q21.1-q22.2 
IKs potassium 
channel beta 
subunit (Mink) 
gain of 
function 
AD 
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current  disease  gene name  
chromosomal 
locus 
Protein 
functional 
effect 
inheritance 
IKr LQT2 KCNH2 7q35-q36 
IKr potassium 
channel alpha 
subunit (hERG) 
loss of 
function 
AD 
 SQT1 KCNH2 7q35-q36 
IKr potassium 
channel alpha 
subunit (hERG) 
gain of 
function 
AD 
 AF2 KCNH2 7q35-q36 
IKr potassium 
channel alpha 
subunit (hERG) 
gain of 
function 
AD 
 LQT6 KCNE2 21q21.1-q22.2 
IKr potassium 
channel beta 
subunit (MiRP) 
loss of 
function 
AD 
 AF6 KCNE2 21q21.1-q22.2 
IKr potassium 
channel beta 
subunit (MiRP) 
gain of 
function 
AD 
IK1 AND/LQT& KCNJ2 17q23.2-q24.2 
IK1 potassium 
channel (Kir2.1) 
loss of 
function 
AD 
 SQT3 KCNJ2 17q23.2-q24.2 
IK1 potassium 
channel (Kir2.1) 
gain of 
function 
AD 
 AF4 KCNJ2 17q23.2-q24.2 
IK1 potassium 
channel (Kir2.1) 
gain of 
function 
AD 
Table 1. Mutations of ion channels 
1.2 Mechanism of ion channels dysfunction 
Based on the discussion mentioned above we can easy to understand the mutation how 
reduce or increase the currents and lead the kinds of cardiac arrhythmia. The change of the 
magnitude of currents in cardiac is based on the below three factors. For instance, the total 
number of channels on the membrane (N), the open probability of the channel (P0) and the 
conductance of single channel (i). Gain of function or loss of function mutations of ion 
channel through changing of N, Po and I alone or all contribute to kinds of congenital 
cardiac arrhythmia.  
1.2.1 Change of the channel number 
There are two distinct process in which can change the number of channel in the plasma 
membrane, one is in the synthesis channel process and another is during the channel 
trafficking.  
About defective synthesis of mutations contained the premature termination codons is 
maybe the most mutations of ion channel. For example, there are one fourths of all 
mutations of hERG channel (http: //www. fsm. it/cardmoc). The protein encoded by the 
mutation with premature termination codon is a truncated one which can be eliminated by 
nonsense-mediated mRNA decay. And the hERG truncation mutation is proved to be clear 
by the nonsense-mediated mRNA decay in recently.  
Exception of the nonsense-mediated mRNA decay, another important clear mechanism is at 
mRNA level by microRNA (miRNA) mediated mRNA silencing. The degradation of the target 
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mRNA is through partial complementary combination with the miRNA followed binding 
with kinds of protein or nucleotide to form a huge ribosome. To date, many miRNA are 
detected in heart and decrease of ion channel protein at translaton or/and transcript levels.   
There are three steps during the process of ion channel synthesis: i) the formation of core-
glycoslyted monomer in ER  followed the correct to the tetramer ii), iii) then complex 
glycaslytaton to form the mature subunit  in Gorgi. Accordingly, Western blot check can be 
utend to detect weather composition of the channel protein is complete. The primarychannel 
protein is common synthesized in ER.  
In order to export completely from the synthesis location (ER), each channel subunit protein 
contained more than one of the ER exit signal (D/E-X-D/E) motif which can guide the protein 
correctly from ER to Golgi, where X represens any kinds of amino acid. To ensure the channel 
deviated from ER, channel form a tetramer in ER by masking or shielding the ER retention 
signal. Therefore, mutations in ER exit signal or with correlation of the assembly of channel 
maybe lead to the retention in ER then decrease the number of channel in the membrane.  
1.2.2 Change of channel open probability 
Change of activation and inactivation maybe are two ways of altering of channel open 
probability. In Xenopus laevis oocytes system, to date many mutations have been detected to 
alter the channel gated. But there are much difference between the oocytes system and the 
mammalian system. In addition, there are many mutations that have been expressed in 
mammalian and shown to result in gating defects.  
1.2.3 Change of single channel conductance 
To alter the conductance of single channel, the mutation sites of ion channel exits in the 
vicinity of the selective filter. Owing to the selective filter of ion channel is determined the 
kinds of ions across the channel. Accordingly, the single channel conductance change may 
be attributed to the conformation altering of the selective filter.  
2. Sodium channel 
Cardiac voltage-gated sodium channel has critical role in excitability of myocardial cells and 
proper conduction of the electrical impulse within the heart. Infux of Na+ across sodium 
channel is responsible for the initial fast upstroke of the cardiac action potential. Therefore, this 
inward sodium channel triggers the initiation and propagation of action potential throughout 
the myocardium. The gene of SCN5A encodes the major sodium channel in heart. 
2.1 Structure of sodium channel  
The voltage-gated sodium channel is composed by a pore-forming  subunit and an 
ancillary  subunit. Nav1.5 encoded by SCN5A consists of four homologous domains (DϨ-
Dϩ) and each domain has six transmembrane segments (S1-S6). Similar to other voltage-
gated ion channel, the S4 contained many positive residues in each domain forms the 
voltage sensor and the S4 and S5 in all domains together make up ion-conductance pore 
including the selectivity filter. When sodium channel is activated, influx of Na+ begin, 
thereby the depolarizing of the membrane until the activation of L-calcium channel, at last 
forming the upstroke of action potential. Continue to depolarization, the fast and low 
inactivation happen causing the sodium channel close. Sodium channel gating properties 
and current kinetics may be altered when channel is dysfunction. 
www.intechopen.com
 
Cardiac Arrhythmias – New Considerations 
 
102 
Cardiac sodium channel function can be regulated by a vast number of proteins. The single 
tansmembrane ǃ-subunit consists of a small C-terminal cytoplasmic domain and a large 
glycosylated N-terminal extracellular domain. The ancillary subunit alters the currents 
density and kinetics by physical interaction with the  subunit. Other proteins regulating 
Nav1.5 by directly binding include ankyrins, fibroblast growth factor homologous factor 1B, 
calmodulin, caveolin-3, Nedd4-like ubiquitin-protein ligases, dystrophin, and syntrophin, as 
well as glycerol-3-phosphate dehydrogenase 1-like protein and MOG1. In addition, sodium 
channel density and kinetics are furthermore also regulated by phosporylation and 
glycosylation, even by changes in temperature.  
2.2 Functions of sodium channel in heart 
During myocardial ischemia, the mechanisms involved in arrhythmogenesis are complex, 
but excitability and conduction are considered as the major determinants. During ischemia, 
local metabolic changes within the myocardium lead to inactivation of the sodium current 
and consequent repression of cardiac excitability and slowing of conduction. In clinical, 
slowing conduction produced by sodium channel blockers application has been shown to be 
proarrhythmic. Some papers have reported an association between SCN5A loss-of-function 
mutations and the occurrence of ischemia-induced severe episodes of ventricular 
tachyarrhythmias. It is as yet unknown whether SCN5A mutations and/or polymorphisms 
play a substantial role in the prevalence of sudden arrhythmic death in the setting of 
myocardial infarction, 
2.3 Cardiac sodium channelopathies 
To date, more than 150 mutations in SCN5A have been reported, the vast majority of them 
caused either LQTS3 and Brugada syndrome. Some patients with LQTS can be healing 
well whereas most of them may increase risk for sudden death due to ventricular 
tachyarrhythmias, in particular torsades de pointes. The character of LQTS3 is that 
display arrhythmias predominantly during rest or sleep videlicet at slow heart rate. 
Therefore, the first clinical event of the patient with LQTS3 often is cardiac arrest rather 
than syncope. About the molecualr mechanism of LQTS, vast majority of mutations in 
SCN5A produced the disruption of the fast inactivation but not the slow inactivation. The 
disruption allows the sodium channel reopen and produces the persistent inward current 
during the action potential plateau phase. Gain of function mutations in sodium channel 
delays the depolarization of the action potential and causes the prolongation of the action 
potential.  
Brugada syndrome, a familial disease which charactered by ventricular arrhythmia and 
sudden cardia death even occuring in healthy person at relatively young age (mainly 
between 30 to 40) and more in male, is first raised by brothers of Brugada in 1992. the 
features on ECG show the elevation of ST segments in the precordial line. Mutation in 
SCN5A is acquired as original of the SQTS3 in a familial disorder in 1998. More than 100 
mutations in SCN5A is related the Brugada syndrome. Besides the mutation in SCN5A, 
mutations in the ǃ-subunits SCN1B and SCN3B, and the regulatory protein GPD1-L have 
been described in some Brugada syndrome patients. In a word, mutations in SCN5A or 
ancillary subunit caused to Brugada syndrome becausing of the reduction of sodium 
channel availabality, loss of function. Some factors cause loss of function in ion channel. 
For example the decreased trafficking will degrade the number of sodium channel (N) in 
membrane surface, or disruption of activation, accelerated inactivation, and impaired 
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recovery from inactivation will alter channel gating properties (the open probability and 
the single channel conductance).  
Loss of mutations in SCN5A underlies the mechanism of progressive cardiac conduntance 
defect (PCCD) due to reduction the sodium channel availability. PCCD is charactered by 
progressive conduction slowing through the His-Purkinje system, leading to the complete 
AV block, syncope and sudden death. Same to PCCD, Sick Sinus Syndrome is also caused 
by the mutations in SCN5A by decreasing the current of inward sodium currents. Sodium 
channel contribute to the cardiac automaticity owe to the inward sodium currents in 
depolarizing progress. Therefore, automaticity of sinoatrial pacemake can also be regulated 
by the sodium channel. Atrial fibrillation is often happened in elderly person with the 
abnormal heart and younger person with normal structure. In recent, both loss of function 
and gain of function mutations in SCN5A have been identified as atrial fibrillation due to 
decrease atrial conductance velocity attributed to the degrade of sodium inward currents 
and increase atrial action potential duration and excitability owe to the raise of sodium 
channel avaibality, respectively. In addition, the patients with dilated cardiomyopathy are 
evoked by the mutations in SCN5A. 
In recent years, “overlap syndrome” of cardiac sodium channel deseases have known  
to exit. The term of “overlap syndrome” is refered to extensive clinical and biophysical 
overlap. For example, the patients with the mutation SCN5A-1795insD+/- shows extensive 
variability in type and severity of symptoms of sodium channel disease. Otherwise,  
the single mutation in SCN5A alone but express pleiotropic effects make further verified 
through a transgenic mice SCN5A-1798insD+/- (equal to human SCN5A-1795insD+/-).  
It is further confirmed that a single SCN5A-1795insD+/- mutation is sufficient to express 
the overlap syndrome of the sodium channel. Heterogenous biophysical properties  
of ion channel mutations causing the mixed disease expressively are now increasing 
recognized. Therefore, it is necessary that improve diagnosis for the sodium 
channelopathies. 
3. Calcium channel 
Voltage gated calcium channel is the main channel across by Ca2+ into the intracellular in 
many excited cell. L-type Cav1.2 channel is an important voltage gated calcium channel 
and have been detected in many organs. Notwithstanding the widespread important 
function of the L-type calcium channel, the mutations have been identified is very rare. 
Mutations of deletion of the pore forming part in Cav1.2 channel change significantly the 
properties of the channel leading to the embryonically lethal. On the contrary, mutations 
associated with mold effects on ICa,L kinetics is well adapted and the patients with no 
obvious symptoms. 
3.1 Structure of L-type CaV1.2 channel 
Similar to the voltage-gated sodium channel, structure of L-type CaV1.2 channel is formed 
by a pore-forming subunit divided for four dormains (from I to II). Each domain consists of 
six transmembrane segments (S1 to S6). As the common to other voltage gated channel, the 
S4 of each domain is the voltage sensor moving across the membrane corresponding to the 
depolarization of the membrane potential. The part of S5, S6 and the linker S5-6 in each 
domain are composed to the ion conduction pathway.  
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Fig. 2. a (cited from Liao and Soong, 2010). Location of the mutations identified in CaV1.2 
pore-forming α1 subunit. Red circles (G402S and G406R) reprents spliced cardiac exon. 
Blue circle (G406R) is located in smooth muscle exon. Purple circles (A39V and G490R) 
represents constitutive exons. b Computer modeling revealed cardiac action potential when 
the mutation in smooth muscle exon and in cardiac exon. 
3.2 Ancillary subunits 
To date, four ǃ subunits of calcium channel genes are expressed in the heart. The ancillary 
subunits can in theory bind to the Cav1.2 subunit at the ǂ1 interaction domain (AID). The 
domain is highly conserved binding motif of 18 amino acid residues present in the 
cytoplasmic linker between repeat I and II of ǂ1 subunits. The ǃ2 subunit is generally 
believed to constitute the intracellular, accessory subunit of the Cav1.2 channel in adult 
mammalian myocardium.  
There are two distinct function of  subunit binding with the pore-forming subunit: before 
binding as a chaperone helping  subunit correct location at the membrane, after binding as 
an allosteric modulator to regulate the kinetic of the currents. Otherwise, different  subunit 
increase the currents of ICa,L at different levels by increasing the the channel opening 
probability, produce distinctive effects on channel inactivation kinetics and induce 
hyperpolarizing shifts in the voltage-dependence of channel activation.  
Recent studies have shown that the ancillary subunits are members of the membrane-
associated guanylate kinase (MAGUK) family of proteins by crystallographic information. 
Therefore, the ancillary subunits, as a ideal targets, interact with other protein such as ahnak 
or various members of the Gem/kir family of small Ras-like GTPase. 
3.3 Functions of L-type Cav1.2 in heart 
The L-type Cav1.2 channel plays a critical and dominant role in triggering excitation-
contraction coupling in cardiomycytes through the influx of the calcium ions to form the 
plateau of the ventricular action potential. Otherwise, the L-type Cav1.2 channel contribute 
to the trigger of the contraction when initiate the Ca2+ from the sarcoplasmic reticulum.  
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LQTS8 (also called Timothy syndrome) is first reported in 1990s with the symptoms of 
syndactyly.  The molecular basis of Timothy Sydrome is the mutations in L-type Cav1.2 at 
IS6 segment encoded by the two mutually exclusive exons 8/8a. Timothy syndrome is 
several features. Firstly, mutations are common caused by the deamination of a methylated 
cytosine to a thymine at de nove. Secondly, gain of function of L-type Cav1.2 lead to the 
increase of current density of ICa,L through slowing the inactivation of the channel. The net 
effects of the mutations increase of intracellular calcium ion. Thirdly, mutations are common 
in the mutually exclusive exons. The mutation of exons alters dramatically channel 
properties and the unaffected exon function normally. Lastly, mutation in Cav1.2 is also 
related to normal function of immune system.  
Different Cav1.2.variants are formed by the extensive alternative splicing by changing the 
pattern of splicing causing a series of disease. Among of them, only a few major splicing site 
can be divided to the cardiac and smooth muscle subfamily. In human heart, Cav1.2 channel 
contained cardiac exon may be 77 percent of all Cav1.2 channel. The first Timothy 
Syndrome mutation G406R is at the smooth muscle exon whereas other mutation G406R 
and F402s is at the cardiac exon. The latter can be named as TS2 and the cardiac arrhythmia 
of what is more serous than TS. 
TS2 mutant Cav1.2 belong to gain of function mutation leading to more calcium ion into the 
cytoplasm. Therefore, the action potential duration are be prolonged and a longer QT 
interval on ECG is shown. Comparision with TS (mutaions at smooth muscle exon), TS2 
(mutations at cardiac exon) produces more effects on action potential duration and 
excitability. For example, the prolongation of action potential duration by mutation at 
cardiac exon and smooth muscle exon is 30% and 8% by computer analysis, respectively. 
Therefore, symptom of patient with TS is molder than one with TS2.  
Otherwise, loss of function mutation in Cav1.2 or ancillary subunit cause to Brugada 
syndrome charactered by the elevating QT segments and shortening QT interval on ECG. 
The ages of the patients with Brugada syndrome is ranging from 21 to 44 years old which is 
elder than TS patients. Besides the dysfunction in cardiac tissues, other organs are nearly 
normal in patient with Brugada syndrome.  
4. Potassium channel 
Potassium channel is the largest family of ion channel protein and divided into voltage- and 
ligand- potassium channel owing to activating by voltage and ligand, respectively. Most of 
potassium channel are determined and depended by membrane potential. The ion-
conducting pore of a K+ channel is formed by four ǂ-subunits that co-assemble as homo- or 
hetero-tetramers with different biophysical properties. Their gating characteristics can also 
be modulated by ancillary subunits or all kinds of blocker or activator.  
4.1 Classification of the cardiac potassium channel 
On the basis of their function, cardiac K+ channels are further classified into the transient 
outward channels, the delayed rectifier channels and the inward rectifier channels (Figure 1). 
Firstly, the transient outward current (Ito) formed by Kv4.3 manifests rapid activation and 
subsequent inactivation during the early repolarization phase (at phase 1). (ii) The delayed 
rectifier channels consist of at least three members Kv1.5, Kv11.1 and Kv7.1, for three 
different currents IKur, IKr, and IKs, respectively. All three channels activate at positive 
potentials but with distinct time courses, for example ultrarapid, rapid, and slow, 
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respectively. Inactivation of IKur and IKs is slow, on the contrary that of IKr is extremely fast. 
(iii) The cardiac inward rectifier potassium channels have more than three components. The 
major classical of one is Kir2,1-2.3 which form IK1 currents. This channel is always open and 
conducts K+ better into than out of the cell. Another channel expressed in atrial myocytes is 
an acetylcholine-dependent channel whicn conducts IK,Ach corresponding with the 
stimulation of G-protein-coupled muscarinic (M2) and adenosine (A1) receptors. The 
activation of IK,ACh shortens the active potential duration (APD). The third one in 
cardiomyocytes is ordinary closed under physiological metabolic conditions and is activated 
when the cells are deprived of intra-cellular adenosine triphosphate (ATP). Similar to IK,ACh, 
IK,ATP causes profound APD shortening.  
Notwithstanding general similarity in the mechanism of action potential arised, the 
distribution of potassium channel in cardiac ventricular myocardium and cardiac atrium is the 
most striking difference. For example, IKur and IK,Ach currents are both detected just in atrial but 
not in ventricular. Under the positive potential IKur is activated rapidly followed by ICa,L 
activation and therefore lead to less positive plateau phase in atrial than ventricular cells. 
4.2 Structure of potassium channel 
Remarkable advances about the structure-function relationship in ion channel have great 
progress in over past 30 years. Especially the progress in two experimental techniques, one 
is the single channel conductance recorded limpidly and plainly by patch clamp and 
another is the first determination at atomic-resolution of the structure of potassium channel 
protein. By means of these techniques, we can monitor real-time behaviour of single 
macromolecule in cell membrane and associate the behaviour with the molecular 
architecture of the protein 
4.2.1 Structures of voltage gated potassium channel 
Voltage-gated potassium channel is a homotetramer formed by each subunit containing six 
transmembrane domains (S1-S6). The pore domain comprise of the S5, the pore helix and S6 
segment. The S1-S4 segments of each subunit form the voltage sensor domains (VSD). The 
part of VCD regulates the open and close of the pore domain through moving across 
membrane in response to change of membrane potential. The channel pore is anisomerous 
and its dimensions change when the transition of channel gates from a closed to an open 
state. The K+-selectivity filter, a narrow cylinder, exists in the extracellular end of the pore 
that optimally utilize for conduction of K+ ions. The difference of the selectivity filter of Kv 
channels with other channel is charactered by the highly conserved sequence Thr-Val-Gly-
Tyr-Gly (the K+ signature sequence), located at the carboxy-terminal end of the pore helix. In 
hERG channel, the Thr and Tyr residues are substituted with Ser and Phe. The hydroxyl 
group of Thr in side-chain and the carbonyl oxygen atoms of the other four residues in each 
subunit all expose to the narrow K+ selectivity filter. These atoms mentioned above (OH- and 
O) encircle several octahedral binding sites that compete with the single water molecule of  
hydrated K+ ions and make a single water molecule alone arranged in a single line pass 
across the filter.  
The central cavity under the selectivity filter is much more widen and is a filled water region 
boundary by the S6 ǂ-helices. In the closed state, the four S6 domains criss-cross near the 
cytoplasmic interface to form a narrow aperture that is too small to permit entry of ions 
from the cytoplasm. In response to membrane depolarization, the S6 ǂ-helices splay 
outwards and increase the diameter of the aperture to allow passage of ions.  
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4.2.2 Structures of Kir channel 
Inward rectifier K+ channels (Kirs) consist of two transmembrane domains (M1 and M2). M1 
and M2, equal to the S5 and S6 part of voltage-gated potassium channel, is connected by a 
pore containing the G(Y/F)G sequence. In addition, the Kirs channels comprise of 
intracellular N- and C-termini. This architecture is typical structure of KATP and Kirchannels. 
They conduct K+ currents more in the inward direction than the outward and play an 
important role in setting the resting potential close to the equilibrium potential for K+ (EK, 
approximately -90 mV for [K+]o = 5 mM) and in repolarization. Kir channels form either 
homo- or heterotetramers. 
About the essential properties of rectification which attributed to blocking of Kir2 channels 
by intracellular organic cations called polyamines response to potent and strongly voltage-
dependent. Of the polyamines, free spermine in cell is the most potent inducer of inward 
rectification, followed by spermidine, putrescine, and then Mg2+. Accordingly, the 
“activation” of inward rectifiers upon membrane hyperpolarization is essentially 
uncoupling of polyamines or Mg2+ from the Kir channel pore.  
The general architecture of the Kir channels and the key structures involved in permeation 
and block is well established. Similar to bacterial homologs, the Kir channel in mammalian 
has a selective filter at the extracellular of the membrane with a signature sequence GYG. 
Under the filter there are a widen water cavity towards the intracellular of the membrane. 
There are a number of residues in Kir2 critical for inward rectification. For example, 
Mutations of D172 located at the level of the water cavity is firstly identified, a ‘rectification 
controller’. Spermine has high affinity with D172 in the vincity of the filter and unbinding 
from the residues highly voltage-dependent. Another important residue in rectification is 
E224 and E299 in the cytoplasmic region which form a ring of acidic. Contrast to D172, 
spermine has a low-affinity binding with E224 and E299 and low voltage-dependent. 
Spermine, as the largest (∼16–18 Å) polyamine, the pore of the Kir2 is long enough to easily 
accommodate two or more spermine.  
In native IK,ACh channels, spermine can also induce strong inward rectification. There are 
half of the residues in underlying Kir3.1/Kir3.4 channels equal to D172 and E224 in Kir2.1. 
The negative residues in Kir3.1/Kir3.4 channels have important role causing strong inward 
rectification. Although Kir2 and Kir3 have many common similarities there are lots of 
differences in the kinetical properties between both of them (Anumonwo and Lopatin, 
2011). 
5. Kv11.1 
Kv11.1 formed a kind of the delayed rectifier currents IKr encoded by KCNH2 which is 
identified as the molecular basis of LQT2 in 1995. To date, nearly 300 different mutations of 
Kv11.1 is the direct reason of congenital LQTs (http://www.fsm.it/cardmoc/; see Table 1) 
and almost all drugs induced acquired LQTS do so through interaction with the hERG 
channel. Besides that, dysfunction of Kv11.1 may cause short QT syndrome and artrial 
fibrillation. Therefore, Kv11.1 has vital role in excitability and action potential conductance 
in heart  
5.1 The features of the structure 
Differences from other Kv potassium channel, hERG channel has a unique extracellular part 
between S5 and the “pore”, so called “S5P linker” that contained an amphipathic helix. With 
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exception of transmembrane segment, hERG has intracellular N-terminal and C-terminal. 
The N-terminal has a Per-Arnt-Sim (PAS) domain which is unique to hERG channe in 
mammalian ion channel and play a role in deactivation of the channel. The C-terminal has a 
cyclic nucleotide binding domain (CNBD) which has relatively little effect on gating by 
binding with cAMP. However, mutation of the domain cause trafficking defects followed by 
loss of function of hERG channel and the last lead to cardiac arrhythmia. 
5.2 Kinetic characters of Kv11.1 
Similar to other Kv potassium channel, hERG channel exits at least three distinct 
conformational states: closed, open and inactivated. Transition from closed to open states or 
from open to inactivated state of channel attributed to the activation or inactivation which 
evokes the constrain of the conduction pathway and disrupted ion translocation. hERG 
channel have significant homology to other Kv family members by sequence analysis. 
However, kinetics characters of hERG channel activation and inactivation is distinct with 
other Kv channel. Contrast with other Kv channel, activation of hERG channel is much 
slower (on ranging from 100s of ms to many second) and inactivation is more rapid (off 
ranging from 1 to 10 ms) and voltage-dependent. Because of the slow activation of hERG at 
depolarized potentials, little outward currents produced by the channel flows through the 
phase 1 and 2 of cardiac action potential. Reduced outward currents conduce to the 
maintenance of the plateau of cardiac action potential by allowing Ca2+ entry and avoid the 
cell refractory to premature excitation. In addition, the increase outward currents, due to the 
much faster recovering from inactivation, is the most important determination  of the 
plateau of cardiac action potential. Besides that the distinct gating kinetics of hERG channel 
leads to form the character IKur currents which is help for suppression of propagation of 
premature beats. Therefore, hERG channel has crucial role in normal or abnormal cardiac 
action potential.  
5.2.1 Activation  
The gate of potassium channel is the bundle crossing formed by four the intracellular 
parts of S6 transmembrane helices of each subunit. The gate at closed state is too narrow 
to allow transverse of K+ ions. Transition to open state attribute to these helices which 
kink at a gate hinge revoking to enlargement of the pore and allow potassium ion pass it. 
In the bacterial KcsA, MthK and KvAP channels, a conserved Gly residue in S6 is 
proposed to serve as the hinge for the activation gate. Mutation of the putative Gly hinge 
in hERG alters gating but does not prevent channel opening. Although Kv1–Kv4 channels 
also have a Gly in the same location, a different molecular hinge may mediate channel 
activation. Therefore, the gating hinge, common formed by PVP motif in Kv1-Kv4, has 
vital roles in change of channel gate whereas the second proline of PVP motif was 
replaced by glycine in hERG channel.  
The S1-S4 VSDs also have important role in regulating the transition from closed to open 
state in voltage-gated potassium channel. The voltage sensor in hERG channel which is the 
six basic positive amino acid every 3 residues localized in the position between 525 and 538 
of the S4 domain Especially, the most important amino acid is the K525, R528 and K538 
conducing to voltage sensing for slow activation. With exception of the positive residues, 
the acidic amino acid in S1-S4 stablize the VSD at open and closed conformation through 
forming salt bridge with S4 residues.  
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It is well known that the voltage sensing regulating the channel open or closed by voltage 
sensor domain (VSDs) up or down across the transmembranes. However, to date the exact 
rearrangement of the structure between up or down and the exact magnitude of movement 
of VSD is still debated. For instance, although the structure of mammalian Kv1.2 channel at 
open state, especially the location of VSD up relative to the membrane have revealed. But 
crystal structure of the channel at closed state scilicet the down relative to the membrane do 
not still detected. Another meaning thing is about the distinct kinetics of the hERG channel 
because the overall of SVD is high homology with other members of Kv channel family by 
analysis sequence and hydropathy plots.  
To find the reason that the kinetics of hERG is so different, many scientists are attracted in 
the field and find several key pieces of evidence. When the gating currents corresponding to 
the movement of voltage sensor domain are measured at the same time the results show 
that a slow time course corresponding with the slow the activation. From the results we can 
conclude that the slow activation of hERG attribute to the slow movements of VSDs 
5.2.2 Inactivation 
About the hERG channel, the mechanism of the inactivation is the C-type at original stage. 
However, hERG inactivation is orders of magnitude faster than C-type inactivation and its 
intrinsically voltage-dependent. Many papers pay attention to the molecular basis of the 
voltage-sensitive of channel inactivation and the relationship between activation and 
inactivation gating, whether the process are couple or completely separate. Some data 
indicate that other part but not the S4 contribute to regulate the hERG inactivation. Ser620 
and Ser 631 in the P-domain are vital for inactivation. In addition, the charge change of S5P 
can markedly alter the inactivation of hERG. Therefore, Perrin conclude that different parts 
of voltage sensor domain participate in regulate the channel activation and inactivation. The 
amphipathic -helix of S5P contain in the regulation of hERG inactivaon, due to the relative 
movements between the -helix of S5P and the pore domain.  
5.2.3 The regulation of KCNE2 
It is well known that KCNE2 (Mirp1) was described as a modulator of the ether-à-go-go-
related gene 1 (ERG1) potassium current. The protein of KCNE2 is a single transmembrane 
peptide with an intracellular C-terminal and an extracellular N-terminal. Coexpression with 
Kv11.1 increase the currents of IKr owing to increasing the single conductance, altering the 
kinetic characters of inactivation and inactivation. Later KCNE2 was found to also change 
the KCNQ1 potassium current by drastically changing the gating properties. Mutations in 
KCNE2 are associated with long QT syndrome (LQT6) (http://www.fsm.it/cardmoc/) 
because of a decreasing influence on both ERG1 and KCNQ1 currents by KCNE2 mutation. 
Accordingly, both types of complexes KCNQ1/KCNE1 and KCNH2/KCNE2 could play a 
functional role in the heart. 
5.3 Functions of Kv11.1 in heart   
Loss of function and gain of function mutations in Kv11.1 produce to the formation and 
conductance of action potential in cardiac tissues. Loss of function mutations decreases the 
currents of IKr due to decrease of channel number, channel open probability and single 
channel conductance as mentioned above. 
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Fig. 3. (adapted from Perrin et al, 2008) Topological map of position of nearly 300 different 
mutations in hERG in LQTS2.  
5.3.1 Congenital cardiac arrhythmia 
LQTs is charactered by the prolongation of QT interval on ECG of the patients. Loss of 
function in Kv11.1 caused LQT2. Defective synthesis of mutations contained the premature 
termination codons is maybe the one fourths of all mutations of hERG channel  
(http: //www. fsm. it/cardmoc). Otherwise, hERG mutation of R534C display an increased 
open probability expressed in Xenopus laevis oocytes whereas in clinically the mutant 
induces the gain of function. Therefore, it is importance of detecting the mutations in 
mammalian system. 
Gain of function mutation in KCNH2 cause increasing of currents amplitude IKr which lead 
to shorten the action potential duration and in final to decurtate the QT interval on ECG. 
Some patients with SQT will be healing well in the future through the regulation of 
themselves. However, if the cardiac action potential is persistent shorten and produce 
diminishing of refractory period between the continual bisaction potential. At last, SQT may 
be get worse the atrial fibrillation and sudden death or syncop. 
5.3.2 Acquired LQTS 
Comparision with congenital LQTS, acquired LQTS is more common cause of TdP. Lots of 
factors can induce to form acquired LQTS, such as myocardial ischemia, electrolyte 
disturbances, bradycardia and so on. Of the most important factors is drug. Accordingly, the 
drug-induced  LQTS is equal to the acquired LQTS in most case. However, acquired LQTS 
and drug-induced LQTS is essential two different concepts.  
Many kinds of drug can induce the acquired LQTS, for instance antiarrhythmia drug, 
antibiotic, antihistamine and so on. Atiarrhythmia drug quinidine is a relatively frequent 
side effects, caused 2-9% of treated patient induced RdP. Other drugs induced TdP is less 
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than antiarrhythmia drugs. The compounds (dofetilide, sotalol and ibutilide), predictable 
designed to block cardiac repolarizing currents, can induce the prolongation of the OT 
interval which unfortunately arises as a side effect of the compound treated for non-cardiac 
diseases. Therefore, the compound in already marketed drugs will be withdrawal or 
restriction. In order to the expenses of the pharmaceutical companies, it is now common 
practice to screen for compound for hERG-channel activity early during preclinical safety 
assessment. However, in clinical the blockage of hERG can counteract by blocking of L-type 
of calcium channel.  
Most of drugs which can induce acquired LQTS can also block of hERG channel. Contrast to 
other Kv channel, the hERG is unusually susceptible to blockage by drugs is unknown, 
suggesting that it has a unique binding site. In order to find the interact sites hERG with the 
blockers, an ala-scanning mutagenesis approach is used. Mutations of two polar residues 
(Thr 623 and Ser 624) located at the base of the pore helix and mutations two aromatic 
residues Tyr652 and Phe656 located in the S6 domain of hERG has vital roles in combination 
with the compounds. The side chains of all four residues are oriented toward the large 
central cavity of the channel and can block the transmembrane pass of potassium ions by 
combining with the blocker. 
5.4 Future perspectives 
Over the past 16 years a great deal of discovery of hERG channel has been detected but 
there is still much to explore about the channel.  
6. Kv7.1  
Kv7.1 (also known as KCNQ1, KvLQT1) is the -subunit of a voltage-gated potassium 
channel cloned in 1996 by Wang and co-workers using linkage analyses of LQTS1 patients 
and expressed in several tissues including cardiac myocytes and epithelial cells. The most 
important roles of KCNQ1 channels are repolarization of the cardiac tissue following an 
action potential. In cardiac myocytes, the KCNQ1 subunit assembles with the KCNE1 -
subunit (minK) to form a channel complex. The channel complex of KCNQ1/KCNE1 
produce the delayed rectifier current IKs, which is partly responsible for terminating the 
cardiac action potential during phase 2. Up to now, there are nearly three hundred mutation 
of KCNQ1 have been detected. Most of the mutations produce the loss of function of 
KCNQ1, lead to the LQTS (http://www.fsm.it/cardmoc/), a most kind of cardiac 
arrhythmia characterized by prolongation of QT interval in electrocardiogram, syncope and 
sudden death. Only a few gain-of function mutations have been verified and have correlate 
with the atrial fibrillation or the short QT syndrome (SQTs). 
Based on the molecular mechanism of altering of KCNQ1 currents, mutations of the channel 
are divided into impaired trafficking, impaired voltage dependence, impaired selectivity 
and impaired tetramerization. For the majority of these three hundred KCNQ1 mutations, 
little is known about the molecular mechanism producing to the pathologies or limited to 
which of the categories. Therefore, there are many unknown knowledge about the three 
hundred KCNQ1 mutaions and make further progress in the future with the application of 
new technology of structure prediction in study. 
6.1 Structure and electrophysiological characters of KCNQ1 
As a member of Kv potassium channel, KCNQ1 channel show a high similarity to voltage-
gated potassium channels of the Kv type which assemble a tetramer, with each subunit of 
www.intechopen.com
 
Cardiac Arrhythmias – New Considerations 
 
112 
KCNQ1 contained S1-S6 trans-membrane. Different from other Kv members, KCNQ1 often 
form heterotetramer with auxiliary subunits contained one-transmembrane in vivo. To date, 
there are five member of KCNE family have been detected and in Xenopus laevis oocytes or 
mammalian system the  subunit of KCNQ1 channel can combinate with any one of them to 
form miscellaneous kinds heterotetramer with distinct kinetic characters of channel such as 
activation, inactivation or deactivation and so on. Accordingly,  subunit of KCNQ1 
channel has been check in lots of tissues in the body and with different physiological 
characters. 
In the full-length human KCNQ1 gene, 16 exons constitute of KCNQ1 with the very GC-rich 
5’-end. The translated protein is composed of 676 residues and has six transmembrane 
domains S1-S6, a pore loop with a typical potassium-channel pore signature sequence 
(GYGD), and intracellular NH2 and COOH terminals covering 122 and 322 residues, 
respectively. To date, with the exception of KCNQ1, there are other four members in the 
KCNQ family have been detected, such as KCNQ2-5. Comparision with other members of 
KCNQ family, KCNQ can not assemble a hetertetramer with other members and just 
forming a homotetramer only with themselves.  
As a voltage-gated potassium channel, KCNQ1 was activated by decreasing of 
depolarization. And similar the other voltage-gated potassium channel, the voltage sensor is 
located in the S4. However, mutations in the linker of between S4 and S5 still have effect on 
activation of the KCNQ1 channel. When KCNQ1 channel are fully open at the positive 
potential followed by a strikingly repolarization produces a hook currents which represent a 
fraction of KCNQ1 channel inactivation. Because the channel will be open again from the 
closed state. Researches show that the five transmembrane and the pore part of each subunit 
have vital roles in the inactivation of KCNQ1 channel.  
6.2 Regulation of KCNQ1 channel activation and inactivation 
As mentioned above, the KCNQ1 subunit and the ancillary subunit KCNE1 collect together 
to form the currents of IKs in cardiac tissues. The KCNE1 subunit has important roles in 
regulation of kinetical properties of KCNQ1 channel. For example, the currents formed by 
KCNQ1 subunit alone is activated rapidly whereas ones formed by coexpressed of KCNQ1 
and KCNE1 is activated very slowly. In addition, the presence of KCNE1 produce a large 
increase in the macroscopic KCNQ1 currents, a positive shift of voltage-dependence curves, 
slowing of the activation and deactivation and almost of absent of inactivation. Some 
researches have shown that the distinguished increase of the magnitude of currents of 
KCNQ1/KCNQ1 complex is owing to increase the single channel conductance for four to 
sevenfold and almost eliminate the inactivation the channel by KCNE1 subunit. As for the 
exact combination of KCNQ1 and KCNE1 subunit, there are distinct views about it. Some 
results display that KCNE1 lines to the conductance pathway. On the contrary other results 
show the combination site is out of the conductance pathway. Van Horn proposes a Q1/E1-
TMD model, a new model to elucidate the interaction of protein-protein about KCNQ1 and 
KCNE1 in recent researches. The emphasis of the new model is on the KCNE1 
transmembrane domain (also called TMD). It is generally accepted that in closed state the 
S4-S5 linker interact with the C-end of S6 from another subunit to lock it in the closed 
configuration. In response to depolarization, the change of conformation of S4 voltage 
sensor, the S4-S5 linker pull off and deviate from the S6 inducing the channel open. The 
Q1/E1-TMD model consider that the C-terminal end of KCNE sits on the end of the S4–S5 
linker while simultaneously N-terminal end makes extensive (and presumably adhesive) 
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contacts in the cleft between the voltage sensor and pore domains of the channel. Therefore, 
during the transition of the channel from closed to open state, the presence of KCNE1 TMD 
will interfere with the S4-S5 linker deviating from the S6. Uniformly, because of the KCNE1 
presence, transition state open to close become very slow and is help for maintenance of the 
open state of the channel.   
Besides the ancillary subunit of KCNE1, there are other members (KCNE2-5) in the family. It 
is interesting that all ancillary subunits can co-assemble with KCNQ1 channel in different 
tissue and alter the kinetic characters of KCNQ1 channel. In cardiac tissue, besides of 
KCNE2, KCNE2 is another important ancillary subunit. KCNE2 (also named Mirp1), 
originally described as a ancillary of the ether-à-go-go-related gene 1 (ERG1) potassium 
current, was later found to change the KCNQ1 potassium current though drastically 
changing the gating properties. Otherwise, in organs such as stomach and intestine, 
Moreover, the mRNA of KCNE4 and KCNE5 has been detected in the heart. They may be 
has vital roles in maintaneine of the ordinary function of the heart. However, there is no 
relative report about it.  
6.3 Functions of KCNQ1 channel in heart 
Currents of IKs formed by KCNQ1/KCNE1 have slow activation, whereas IKur and IK1 
constituted by ERG1 and Kir2.x, respectively, have rapide activation kinetics. The three 
repolarizing potassium currents together have been called the repolarization reserve 
because to some extent they can substitute for each other. However, in the fast heart beat, 
only IKs currents are upregulated by phosphorylation and by current accumulation due to 
slow deactivation. In addition, In heart tissue, distribution of KCNQ1 through the cardiac 
wall is also inhomogeneous and the expression of KCNQ1 is less in medmyocardium than 
epi- and endomyocardium.  
The cardiac function of KCNQ1 and its accessory subunits is emphasized by the functional 
impact of numerous mutations in these proteins (http://www.fsm.it/cardmoc/). Mutations 
in KCNQ1 causing loss of function by trafficking defective, assembly defective, or single 
channel conductance lead to prolonged action potentials and LQTS. A domain located near 
the COOH terminal (residues 589–620) is responsible for this assembly specificity, and 
deletion of a part of this domain leads to an impaired assembly of the channel complexes 
followed by mistrafficking. Mutations in ancillary subunits such as KCNE1 and KCNE1 also 
cause LQTS4 and LQTS5, respectively.  
KCNQ1 mutation (S140G), as a gain of function mutation, is detected in a family with 
arterial fibrillation inherited as an autosomal dominant way through four generations. The 
mutation shortens the action potential through increasing the currents of IKs. Similarly, a 
gain-of-function mutation in KCNE2 (R27C) increasing the activity of the KCNQ1/KCNE2 
channel has also been implicated in atrial fibrillation. 
Acquired LQTS is predominantly found when the patients take the blocker of hERG channel 
as medicine. Because the currents of IKr are blocked, the repolarization reserve is decreased 
and the disperation of repolarization is leaded to a further increase due to the 
inhomogeneous distribution of KCNQ1 in heart wall.  
7. Kv4.3  
Kv4.3 is formed the rapid activated currents Ito (encoded by KCND3) which is a voltage-
dependent, 4-aminopyridine (4-AP) sensitive, calcium-independent K+ current (Ito). Ito have 
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been detected in human artial and ventricular myocytes and is responsible for the early 
rapid depolarization (at phase 1) so determining the height of plateau. Therefore, Ito will 
influence of other ion channel activation such as the L-type calcium channel and the delayed 
rectifier channel (KCNQ1). Distribution of Kv4.3 is heterogeneous through the cardiac 
tissue. For example, Ito density in atrial tissue, Purkinje fibers, epicardial and midmyocardial 
(M) cells is higher than in the endocardial cells. The prominent epicardial Ito conduce to the 
depression of epicardial in ischemia and to the progress of a significant dispersion of 
repolarization between normal and ischemic epicardium, between epicardium and 
endocardium.  
7.1 Regulation of Kv4.3  
Kv4.3 can be blocked by many compounds but which bind with the channel either at open 
state or at close state. It has been raised that blocker of Ito prolong the action potential duration 
in atria or in ischemic ventricular tissues. However, blockage of Ito subsequently changes the 
other potassium channel underlying during repolariztion of cardiac action potential. 
Reduction of Ito magnitude can shorten the duration of ventricular action potential. Therefore, 
it is still unclear that the exact role in control human cardiac action potential. 
Channel properties of Kv4.3 is modified by the phosphorylation, mediated by protein kinase 
A (PKA) and C (PKC) through altering the channel kinetic (activation, inactivation or single 
channel conductance) and the expression of active channel in the membrane. Decrease in Ito 
by PKC attributed to enhance the inactivation and step down the time of deactivate of the 
channel Kv4.3. a-adrenergic agonists reduce Ito magnitude in rat ventricular myocytes and 
oppositely the -adrenergic agonists has no effect on Ito currents. 
7.2 Functions of Kv4,3 in heart 
Heart failure, cardiac hypertrophy and myocardial ischemia and infarction decrease the 
magnitude of Ito resulting in the prolongation of action potential. The degrade in Ito in heart 
failure may be adaptive in the short-term because increased depolarization during the 
cardiac cycle means that more time is available for excitation–contraction coupling, which 
moderate the decrease in cardiac output, however it becomes maladaptive in the long-term, 
because a prolongation of the APD may contribute to arrhythmogenesis, either by causing 
inhomogeneous repolarization or by increasing the likelihood of early afterdepolarizations. 
On the contrary, it is proved that up-regulation of Ito in cardiac hypertrophy and in cardiac 
myocytes after induced myocardial infarction. Increase in Ito presents as a protector 
moderating the excessive prolongation of action potential duration and Ca2+ inflow to 
minimize the incidence of ventricular arrhythmia. In addition, the patients with chronic 
atrial fibrillation decrease the currents of Ito and downregulate the mRNA.  
8. Kv1.5 
Ikur currents in human atrium are formed by the  subunit (Kv1.5) and  ancillary subunit 
(Kv1.2). The features of IKur, as outward rectifired currents, are activated rapidly in the 
plateau range and inactivation slowly. Interestingly, currents of IKur just have been detected 
in human atria rather than cardiac ventricle. Therefore, currents of IKur have vital roles 
during the atrial repolarization. There is a huge difference of Kv1.5 from other ion cardiac 
channel. Distribution of Kv1.5 is homogeneous across the atrial wall.  
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8.1 Regulations of Kv1.5 
hKv1.5 can be regulated by both PKA and PKC. One consensus site in Kv1.5 for 
phphosphorylation by PKC is located on the extracellular S4–S5 linker and 4 consensus 
sites for PKA is located in the N- and C-terminal domains. Isoproterenol and adenylate 
cyclase both increase the magnitude of IKur and the increase can be counteract by PKA 
inhibitor. Otherwise, propranolol and phenylephrine decrease the amplitude of IKur 
moderating by the PKC inhibitor. Accordingly, -adrenergic stimulation enhances the 
currents of IKur by PKA. Oppositely, -adrenergic stimulation inhibits IKur currents by 
PKC. Human thrombin or rat 5-HT1c receptors inhibits the currents of IKur by increasing 
phospholipase C (PLC). Moreover, the Scr tyrosing kinase inhibits the hKv1.5 by 
phosphorylation of the N-terminus proline-rich sequences mediated by SH3 domain of 
the tyrosine kinase.  
8.2 Functions of IKur in heart 
IKur is relatively insensitive to TEA, Ba2+ and class III antiarrhythmics of the 
methanesulfonanilide group. Antiarrhythmia drug is often weak bases that predominant 
cationic ion at pH7. At the channel open state, the cationic ion can bind with the pore 
and/or selective filter domain of the channel leading to the blockage of the channel. The 
binding site for some drugs is existed at the external mouth of the channel pore formed by 
the P loop and adjacent S5–S6 segments.  
Because of the Kv1.5 just located in atria, the channel is a promising target for the 
development of new safe antiarrhythmic drugs to prevent atrial fibrillation and without a 
risk of ventricular proarrhythmia. However, In patients in chronic artrial fibrillation, the 
action potential duration in atria is significantly prolongated due to both blockage of Ica,L 
and IKur. Accordingly, it is not expected what will be happened by use of IKur blocker to treat 
the patient with chronic AF. In a rat, rapid atrial pacing just immediately and transiently 
increases the mRNA of Kv1.5 rather than the ones of KCNQ1 and hERG. It shows that Kv4.3 
at least in part contribute to the rapid shortening of the atrial refractoriness at the onset of 
AF. Therefore, the selective blockers of IKur counteract the shortening of atrial action 
potential duration at rapid rate state. From mentioned above, application of IKur selective 
blocker in clinical is a challege job in the future.  
9. Kir2.1 and Kir3 
Inward rectifiers (Kir) is composed of a large family of potassium channel. Among them, 
only two subfamilies (Kir2 and Kir3) share great structural similarity and underlie classical 
‘strong inwardly rectifying currents’ originally observed in skeletal and cardiac muscle. In 
cardiac tissue, there are only two similar types of these currents: (1) IK1, as a constitutively 
active Kir current, is more prominent in ventricular tissue, and (2) IK,Ach, as a receptor-
activated Kir current, is more prominent in atrial tissue, as well as in SA node and AV node. 
There are two common features of the kir2 and Kir3. one is a strongly voltage-dependent 
decline of potassium conductance upon membrane depolarization producing a 
characteristic region of so-called ｀negative slope’ conductance. Another unique property of 
Kir currents is the unusual dependence of rectification on extracellular K+. In order to 
comprehend the two characters of Kir channel, firstly to fully the molecular basis of the 
channels.  
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Fig. 4. (cited from Anumonwo et al, 2009). The family of inward rectifier potassium 
channels. All members of this family share significant structural similarity, but only Kir2 
and Kir3 subfamilies represent channels carrying classical strongly rectifying currents.  
In human heart, the distribution of IK1 and IK,Ach has distinct region. IK1 is more prominent in 
the ventricles, including Purkinje myocytes. IK,Ach has generally an opposite distribution to 
that of IK1. It is more prominent in the atria than in ventricles. Similarity, the current density 
of IK1 and IK,Ach may vary across the ventricular or atrial tissues, distinctively. About the 
subunit composition of IK,Ach, under normal conditions native IK,Ach channels are heteromers 
of Kir3.1/ Kir3.4 subunits. However, recent data suggest that Kir3.4 subunit alone has 
similar function with the native IK,Ach. Comparision with IK,Ach, IK1 is formed by coassembly 
of the Kir2.1.x subfamily of proteins (Kir 2.1, 2.2, and 2.3) with Kir2.1 the most abundant 
subtype in ventricular tissue.  
9.1 Functions of Kir2 and Kir3 in heart 
To date, IK1, formed by coassembly of the Kir2.1.x subfamily of proteins (Kir 2.1, 2.2, and 2.3) 
In cardiac tissue, is the major component of inward rectifier potassium current and have a 
vital role in determinant of the resting membrane potential and conduces to the terminal 
phase of repolarization (phase 3). Loss of function of Kir2 channel ≥ 90%, the heart of 
transgene (TG) mice led to prolongation of QRS and QT intervals as well as expected 
prolongation of action potential. Surprisingly, resting membrane potential in TG ventricular 
myocytes was nearly unaffected. It is unexpectedly that upregulation of IK1 in TG mice 
expressing Kir2.1 subunits, gain of function, cause to multiple abnormalities of cardiac 
excitability contained significant AP shortening and various types of atrial and ventricular 
arrhythmias. 
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In heart, another contribution of IK1 to excitability is through an unusual and strong 
dependence on extracellular K+. During repetitive firing, cardiac activity is followed by 
markedly changes in the concentration of K+ in the restricted (0.01–5 μM) intercellular space, 
even more accumulation in the t-tubules. Increase of extracellular K+ should be 
accompanied by the increase of IK1 conductance with results on electrical activity, e.g., AP 
duration and propagation  
 
 
Fig. 5. (cited from Anumonwo et al, 2009). Mutations on Kir2.1 protein associated with 
channelopathies of the classical inward rectifier channel. Mutant residues are color coded to 
represent the long QT7 (LQT7; black), catecholaminergic polymorphic ventricular 
tachycardia (CPVT; red), familial atrial fibrillation (FAF; green), and short QT3 (SQT3; blue). 
To date, four channelopathies related with inward rectifier currents have been detected, all 
due to loss of function or gain of function of IK1 currents (encoded by KCNJ2), LQT7, 
catecholaminergic polymorphic ventricular tachycardia (CPVT), familial atrial fibrillation 
(FAF), and short QT3. LQT7 at early is also called Andersen syndrome (AS) or Andersen–
Tawil syndrome (ATS). Symptoms of the disease are characterized by a triad of clinical 
phenotypes affecting morphogenesis as well as the functioning of skeletal and cardiac 
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muscles. ATS patients are often companied by features that include scoliosis, cleft palate, 
and short stature and display skeletal muscle weakness. Besides that, cardiac electrical 
abnormalities include prolongation of the QT interval, short runs of ventricular tachycardia, 
ventricular bigeminy and multi-focal ventricular ectopy mediated by adrenergic 
stimulation. However, recent works suggest that classification of ATS into LQTS is incorrect 
because of the former largely related to the abnormalities of the T–U complex. Because more 
than half of ATS is the mutations in KCNJ2 the term AST1 is reffered to the disease of IKir2. 
To date, more than 33 mutation in KCNJ2 is related to AST1 and the mutations have been 
identified as the autosomal-dominant. Some of mutations, such as D71V in AST1 patients, 
can decrease by ∼94% of  the magnitude of wild type currents IKir2. Several of ATS1 
mutations, such as R21Q/W mutations, result in a loss-of function in the Kir2.1 channels due 
to reduced interaction with membrane PIP2.  
Short QT syndrome (SQTS) is charactered by the shorten of QT interval on ECG. SQTS is an 
inherited abnormality that predisposes afflicted individuals to a high risk of having 
fibrillation (atrial/ventricular) and sudden death. Three forms of SQTS have been identified 
and SQTS3 is caused by the gain of function of mutations in inward rectifier channel gene, 
KCNJ2. SQTS3, charactered by electrocardiographic phenotype with asymmetrical T waves, 
is distinguished with other two kinds of SQTS. The molecular basis of SQTS3 is the mutation 
D172N at a position critical for inward rectification of Kir2.1 channel. Heterologous 
coexpression of wild type and mutant Kir2.1 subunits showed increased outward currents 
in mutant channels which account for the tall, asymmetrical T waves on the ECG of LQTS3 
patients. Researches by computer simulations suggest that mutations in SQT3 might 
predispose patients to a higher risk of reentrant arrhythmias. 
Mutation of V93I in Kir2.1 is associated with familial atrial fibrillation, thereby implicating 
IK1 in this disease. In addition, the mutant channels have larger outward currents by whole-
cell patch-clamp studies, however the underlying mechanism(s) responsible for the increase 
remains unknown.  
In a recent study, three novel (R67Q, R85W, and T305A) mutations belonged to CPVT3 and 
one previously described (T75M) mutations in KCNJ2 are identified. ECG analysis reveals 
prominent U-waves, ventricular ectopy, and polymorphic ventricular tachycardia. It is 
interestingly that there were no dysmorphic features or skeletal muscle abnormalities in the 
patients. Whole-cell patch-clamp experiments revealed that mutant channels had 
significantly reduced by ≥ 95 % amplitude of wild type outward current and that T75M and 
R67Q mutations had dominant negative effects when co-expressed with wild type channels. 
Importantly, the study showed that the T305A mutation selectively affected channel 
rectification properties.  
Cardiac strong inward rectifier potassium channels continue to surprise researchers with 
their novel roles in cardiac excitability, complex structure, function, and regulation. While 
significant progress has been made in recent years, clearly, many questions still remain to be 
answered and we certainly will soon witness new, and likely unexpected, discoveries in this 
field. 
10. Kir6.2 
ATP-sensitive potassium (KATP) channels (encoded by KCNJ11) are evolutionarily conserved 
and are first discovered in the cardiac sarcolemma where they are expressed in high density. 
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IKATP is formed by the complex protein composed by the pore-forming subunit and the 
regulatory sulfonylurea receptor which is an ATPase-harboring ATP-binding cassette 
protein. To date, members of the inwardly rectifying K+ channel family (Kir6.1 and Kir6.2) 
and the sulfonylurea receptor isoforms (SUR1, SUR2A and SUR2B) have been identified. In 
cardiac tissue, KATP channel is a hetero-octameric complex composed of four pairs of these 
two distinct subunits Kir6.2 and SUR2A. The structure of KATP channel is very similar to 
Kir3 and Kir2. Therefore, there is no redundant description in this part.  
10.1 Functions of KATP channels in heart 
KATP channels, as a cardio-protective role, were recognized early in ischemia heart. The 
channel can mediate shortening of the cardiac action potential by increase of the IKATP 
currents then control calcium influx into the cytosol. Moreover, when the heart expose to a 
brief periods of ischemia causing a sustained ischemic insult KATP channel activity can 
depress significantly the injury produced by ischemia such as infarct size, coined ischemic 
preconditioning. Therefore, in ischemia heart, KATP channel can degrade markedly heart 
injure caused by ischemia.  
Another important function of KATP channel is during the process of stress without 
distress in heart. The concept of “stress without distress” is referred to describe the ability 
of an organism to confront and/or escape imposed threat. The concept is very likewise to 
the “flight-or-fight” response, through the general adaptation syndrome. For example, 
acute exercise-stress causes a systemic sympathetic stimulation that raises cardiac 
contractility, heart rate and thereby provides the necessary higher cardiac output. How 
huge change of the heart excitability has happened after acute exercise. Many researches 
suggest that stress without distress is dependent in the KATP channel in heart. The change 
of this enhanced cardiac output imposes a significant metabolic in large part of the heart 
due to the highly energy consuming calcium handling machinery. A compensatory 
increase in outward potassium current formed by KATP channel is normally activated to 
offset the resulting calcium influx in order to reducing energy-demanding myocardial 
calcium overload.  
KATP channel also has important roles in heart failure. Heart failure has no effect on the 
intrinsic biophysical properties of the cardiac KATP channel whereas the structural 
remodeling disrupts communication of energetic signal and channel.  Then the disruption 
leads to interfere markedly the metabolic regulation of the channel at last. Accordingly, 
metabolic dysregulation of KATP channels created by the disease-induced structural 
remodeling appears to contribute to the dysfunction of heart failure. 
11. Acknowledgment 
The paper is supported by a start-up grant from Henan University of Technology 
(2009BS006). 
12. References 
Anumonwo JMB, Lopatin AN. 2010. Cardiac strong inward rectifier potassium channels. J 
Mol Cell Cardiol 48: 45–54 
Delisle BP, Anson BD, Rajamani S, January CT. 2004. Biology of cardiac arrhythmias ion 
channel protein trafficking. Circ. Res 94: 1418-1428 
www.intechopen.com
 
Cardiac Arrhythmias – New Considerations 
 
120 
Fowler SJ, Cerrone M, Napolitano C, Priori SG. 2010. Genetic testing for inherited cardiac 
arrhythmias. Hellenic J Cardiol 51:92-103 
Haase H. 2007. Ahnak, a new player in ǃ-adrenergic regulation of the cardiac L-type Ca2+ 
channel. Cardiovasc Res 73: 19–25. 
Jespersen T, Grunnet M, Olesen SP. 2005. The KCNQ1 Potassium Channel: From Gene to 
Physiological Function. Physiology 20:408-416. 
Jeyaraj D, Ashwath M, and Rosenbaum DS. 2010. Pathophysiology and clinical implications 
of cardiac memory. Pacing Clin Electrophysiol 33(3): 346–352. 
Liao P, Soong TW. 2010. CaV1.2 channelopathies: from arrhythmias to autism, bipolar 
disorder, and immunodeficiency. Eur J Physiol 460:353–359 
Pero D, Rodriguez N, Choveau F, Baró I, Mérot J, Loussouarn G. 2008. Kv7.1 (KCNQ1) 
properties and channelopathies. J Physiol 586.7: 1785-1789 
Perrin MJ, Subbiah RN, Vandenberg JI, Hill AP. 2008. Human ether-a-go-go related gene 
(hERG) K+ channels: function and disfunction. Prog biophy molr bio 98: 137-148 
Ravens U, Cerbai E. 2008. Role of potassium currents in cardiac arrhythmias. Europace 10: 
1133–1137 
Remme CA, Bezzina CR. 2010. Sodium channel (Dys) Ffunction and cardiac arrhythmia. 
Cardiovasc ther 28: 287-294.  
Sanguinetti MC, Tritani-Firouzi M. 2006. hERG potassium channels and cardiac arrhythmia. 
Nature 466: 463-469  
Sicilian G. 1991. A new approach to the classification of antiarrhythmic drugs based on their 
actions on arrhythmogenic mechanisms. Task Force of the Working Group on 
Arrhythmias of the European Society of Cardiology. Circulation 84:1831–51. 
Sung RJ, Wu YH, Lai NHJ, Teng CH, Luo CH, Tien HC, Lo CP, Wu SN. 2010. -Adrenergic 
modulation of arrhythmogenesis and identification of targeted sites of 
antiarrhythmic therapy in Timothy (LQT8) syndrome: a theoretical study. Am J 
Physiol Heart Circ Physiol 298: H33–H44, 
Tristani-Firouzi M, Etheridge SP. 2010. Kir 2.1 channelopathies: the Andersen–Tawil 
syndrome. Eur J Physiol 460:289–294 
Ufret-Vincenty CA, Baro DJ, Lederer WJ , Rockman HA,. Quiňones LE, and Santana LF. 
2001. Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias 
in heart failure. J Biol Chem 276 (30): 28197–28203 
Van Horn WD, Vanoye CG, Sanders CR. 2011. Working model for the structural basis for 
KCNE1 modulation of the KCNQ1 potassium channel. Currt Opin Struc Biol 21:283–
291 
www.intechopen.com
Cardiac Arrhythmias - New Considerations
Edited by Prof. Francisco R. Breijo-Marquez
ISBN 978-953-51-0126-0
Hard cover, 534 pages
Publisher InTech
Published online 29, February, 2012
Published in print edition February, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The most intimate mechanisms of cardiac arrhythmias are still quite unknown to scientists. Genetic studies on
ionic alterations, the electrocardiographic features of cardiac rhythm and an arsenal of diagnostic tests have
done more in the last five years than in all the history of cardiology. Similarly, therapy to prevent or cure such
diseases is growing rapidly day by day. In this book the reader will be able to see with brighter light some of
these intimate mechanisms of production, as well as cutting-edge therapies to date. Genetic studies,
electrophysiological and electrocardiographyc features, ion channel alterations, heart diseases still unknown ,
and even the relationship between the psychic sphere and the heart have been exposed in this book. It
deserves to be read!
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Jing Hongjuan and Zhang Lu (2012). Contributions of Ion Channels in Cardiac Arrhythmias, Cardiac
Arrhythmias - New Considerations, Prof. Francisco R. Breijo-Marquez (Ed.), ISBN: 978-953-51-0126-0,
InTech, Available from: http://www.intechopen.com/books/cardiac-arrhythmias-new-
considerations/contributions-of-ion-channels-in-cardiac-arrhythmias
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
